Salomon H - Search Results

1

Higher rate of toxicity with no increased efficacy when hydroxyurea is added to a regimen of stavudine plus didanosine and nevirapine in primary HIV infection.

Zala C, Salomon H, Ochoa C, Kijak G, Federico A, Perez H, Montaner JS, Cahn P. Zala C, et al. Among authors: salomon h. J Acquir Immune Defic Syndr. 2002 Apr 1;29(4):368-73. doi: 10.1097/00126334-200204010-00007. J Acquir Immune Defic Syndr. 2002. PMID: 11917241 Clinical Trial.

2

Treatment of primary HIV infection: a pilot study of stavudine and didanosine plus nevirapine with or without hydroxyurea.

Zala C, Salomón H, Cahn P. Zala C, et al. Among authors: salomon h. Antivir Ther. 1999;4 Suppl 3:95-9. Antivir Ther. 1999. PMID: 16021880

3

Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters.

Socías ME, Sued O, Laufer N, Lázaro ME, Mingrone H, Pryluka D, Remondegui C, Figueroa MI, Cesar C, Gun A, Turk G, Bouzas MB, Kavasery R, Krolewiecki A, Pérez H, Salomón H, Cahn P; Grupo Argentino de Seroconversión Study Group. Socías ME, et al. Among authors: salomon h. J Int AIDS Soc. 2011 Aug 10;14:40. doi: 10.1186/1758-2652-14-40. J Int AIDS Soc. 2011. PMID: 21831310 Free PMC article.

4

Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in Argentina.

Kijak GH, Pampuro SE, Avila MM, Zala C, Cahn P, Wainberg MA, Salomón H. Kijak GH, et al. Among authors: salomon h. Antivir Ther. 2001 Mar;6(1):71-7. Antivir Ther. 2001. PMID: 11417764

5

Discrepant results in the interpretation of HIV-1 drug-resistance genotypic data among widely used algorithms.

Kijak GH, Rubio AE, Pampuro SE, Zala C, Cahn P, Galli R, Montaner JS, Salomón H. Kijak GH, et al. Among authors: salomon h. HIV Med. 2003 Jan;4(1):72-8. doi: 10.1046/j.1468-1293.2003.00131.x. HIV Med. 2003. PMID: 12534963 Free article.

6

Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure.

Kijak GH, Simon V, Balfe P, Vanderhoeven J, Pampuro SE, Zala C, Ochoa C, Cahn P, Markowitz M, Salomon H. Kijak GH, et al. Among authors: salomon h. J Virol. 2002 Jul;76(14):7000-9. doi: 10.1128/jvi.76.14.7000-7009.2002. J Virol. 2002. PMID: 12072500 Free PMC article.

7

Low rate of emergence of nevirapine and lamivudine resistance after post-partum interruption of a triple-drug regimen.

Pérez H, Vignoles M, Laufer N, Gómez A, Coll P, Lottner J, Rolón M, Salomón H, Cahn P. Pérez H, et al. Among authors: salomon h. Antivir Ther. 2008;13(1):135-9. Antivir Ther. 2008. PMID: 18389908

8

Mother-to-child transmission of drug-resistant HIV.

Kijak GH, Avila MM, Salomón H. Kijak GH, et al. Among authors: salomon h. Drug Resist Updat. 2001 Feb;4(1):29-37. doi: 10.1054/drup.2001.0182. Drug Resist Updat. 2001. PMID: 11512150 Review.

9

HIV type 1 genetic diversity is a major obstacle for antiretroviral drug resistance hybridization-based assays.

Kijak GH, Rubio AE, Quarleri JF, Salomón H. Kijak GH, et al. Among authors: salomon h. AIDS Res Hum Retroviruses. 2001 Oct 10;17(15):1415-21. doi: 10.1089/088922201753197088. AIDS Res Hum Retroviruses. 2001. PMID: 11679154

10

HCV genotype distribution among HIV co-infected individuals in Argentina: relationship with host and viral factors.

Quarleri JF, Bolcic FM, Bouzas MB, Laufer N, Gómez Carrillo M, Mammana L, Kaufman S, Pérez H, Cahn P, Salomon H. Quarleri JF, et al. Among authors: salomon h. Acta Gastroenterol Latinoam. 2007 Jun;37(2):76-83. Acta Gastroenterol Latinoam. 2007. PMID: 17684937

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page